Speech-based Digital Biomarker for Psychiatric Disease

NCT ID: NCT04851912

Last Updated: 2022-09-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-04-27

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The general objectives of this study are to build a proof-of-concept, speech-based, digital biomarker for identifying the presence and tracking the severity of psychiatric disease.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this study is to gather longitudinal data to examine how speech features and symptoms change over different intervals of time and the reliability of repeated, high frequency test administration. Participants will complete a variety of speech and language tasks using the Winterlight Assessment (iOS app) everyday for 30 days. The following is the list of assessments that participants will complete; 1) Daily assessment of mood, 2) Winterlight assessment which contains a series of verbal response tasks where participants are recorded through a tablet app, and 3) Clinical assessments.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Speech Psychiatric Disorder Language

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

General

Participants with or without psychiatric disorders

Winterlight Apps

Intervention Type OTHER

Longitudinal speech recordings

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Winterlight Apps

Longitudinal speech recordings

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male and Female adults aged 18 to 95.
* English as a first language, or English as a second language with conversational proficiency.
* Own an iOS device (iPhone or iPad) and willing to install the study app.
* A reliable (cellular or WiFi) home internet connection and accessible email address

Exclusion Criteria

* Residence outside of Canada or the United States.
* Clinically significant vision impairment (corrected vision is acceptable).
* Clinically significant hearing impairment (use of hearing aids is acceptable)
Minimum Eligible Age

18 Years

Maximum Eligible Age

95 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Winterlight Labs

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jessica Robin, PhD

Role: PRINCIPAL_INVESTIGATOR

Clinical Research Director, Winterlight Labs

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Winterlight Labs

Toronto, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

WLL-PRO-005

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Digital Care Programs for Mental Health
NCT07183085 ENROLLING_BY_INVITATION